Earnings History Data for Altimmune, Inc. (ALT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Altimmune, Inc.
Altimmune, Inc. is a clinical-stage immunotherapeutics company. It focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease. The company's proprietary platform technologies consist of RespirVec and Densigen. Altimmune Inc., formerly known as Pharmathene Inc., is based in Gaithersburg, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27-03-2024 | PM | ALT | Altimmune, Inc. | 458.31 | -0.33 | -0.34 | -0.43 | Altimmune GAAP EPS of -$0.54 misses by $0.16 [3/27/2024 7:02 AM] |
8.89 | 0.24 (2.77%) |
9.30 | 0.65 (7.51%) |
2.09 - 14.84 | 7,624,022 | 4,140,000 | 2,827,931 | ||
| 07-11-2023 | PM | ALT | Altimmune, Inc. | 144.36 | -0.39 | -0.40 | -0.48 | Altimmune GAAP EPS of -$0.39 beats by $0.03, revenue of $0.36M beats by $0.36M [11/7/2023 7:04 AM] |
2.71 | 0.04 (1.50%) |
2.76 | 0.09 (3.37%) |
2.09 - 17.17 | 1,536,706 | 1,590,000 | 19,634 | ||
| 10-08-2023 | PM | ALT | Altimmune, Inc. | 148.37 | -0.32 | -0.44 | -0.42 | Altimmune GAAP EPS of -$0.32 beats by $0.13 [8/10/2023 7:01 AM] |
3.04 | 0.09 (3.05%) |
3.02 | 0.07 (2.44%) |
2.89 - 23.49 | 2,076,417 | 1,250,000 | 28,645 | ||
| 11-05-2023 | PM | 7:00 AM ET (May 11) |
ALT | Altimmune, Inc. | 243.44 | -0.40 | -0.49 | -0.44 | Altimmune GAAP EPS of -$0.40 beats by $0.08 [5/11/2023 7:01 AM] |
5.33 | 0.35 (7.13%) |
5.01 | 0.03 (0.60%) |
3.82 - 23.49 | 1,484,217 | 1,140,000 | 7,031 | |
| 28-02-2023 | PM | 7:00 AM ET (Feb 28) |
ALT | Altimmune, Inc. | 573.69 | -0.43 | -0.52 | -0.49 | Altimmune GAAP EPS of -$0.43 beats by $0.11 [2/28/2023 7:03 AM] |
12.57 | 0.74 (6.26%) |
11.91 | 0.08 (0.68%) |
3.83 - 23.49 | 705,718 | 950,000 | 1,729 | |
| 10-11-2022 | PM | 7:00 AM ET (Nov 10) |
ALT | Altimmune, Inc. | 509.37 | -0.48 | -0.49 | -0.81 | Altimmune GAAP EPS of -$0.48 beats by $0.01 [11/10/2022 7:02 AM] |
10.55 | 0.86 (8.88%) |
10.07 | 0.38 (3.92%) |
3.83 - 23.49 | 1,343,351 | 1,260,000 | 810 | |
| 11-08-2022 | PM | 7:00 AM ET (Aug 11) |
ALT | Altimmune, Inc. | 565.31 | -0.42 | -0.45 | -0.40 | Altimmune GAAP EPS of -$0.42 beats by $0.05, revenue of $8K [8/11/2022 7:03 AM] |
13.75 | 0.89 (6.92%) |
12.91 | 0.05 (0.39%) |
3.83 - 17.26 | 1,162,278 | 1,390,000 | 28,213 | |
| 12-05-2022 | PM | 7:00 AM ET (May 12) |
ALT | Altimmune, Inc. | 184.56 | -0.44 | -0.57 | -0.38 | Altimmune GAAP EPS of -$0.44 beats by $0.14, revenue of $0.03M misses by $0.85M [5/12/2022 7:02 AM] |
4.29 | 0.35 (8.76%) |
3.95 | 0.01 (0.25%) |
3.83 - 19.46 | 768,620 | 740,000 | 236 | |
| 15-03-2022 | PM | 4:00 PM ET (Mar 14) |
ALT | Altimmune | 297.00 | -0.49 | -0.64 | 0.00 | Altimmune GAAP EPS of -$0.57 beats by $0.08, revenue of $3.28M beats by $3.19M [3/15/2022 7:42 AM] |
5.86 | -0.57 (-8.94%) |
6.60 | 0.17 (2.64%) |
5.78 - 19.46 | 1,140,393 | 745,076 | 29,489 | |
| 17-05-2021 | PM | 7:00 AM ET (May 17) |
ALT | Altimmune, Inc. | 492.99 | -0.38 | -0.39 | -0.26 | Altimmune EPS beats by $0.28, misses on revenue [5/17/2021 7:05 AM] |
14.18 | 0.80 (5.98%) |
13.15 | -0.23 (-1.72%) |
4.36 - 35.10 | 890,393 | 770,000 | 3,848 | |
|
||||||||||||||||||
| 25-02-2021 | PM | Before the open (Feb 25) |
ALT | Altimmune, Inc. | 851.69 | -0.17 | -0.84 | -0.25 | Altimmune EPS beats by $0.68, beats on revenue [2/25/2021 7:19 AM] |
17.15 | -2.43 (-12.41%) |
19.00 | -0.58 (-2.96%) |
1.60 - 35.10 | 2,268,333 | 1,703,678 | 29,058 | |
|
||||||||||||||||||
| 09-11-2020 | AH | 7:15 AM ET (Nov 10) |
ALT | Altimmune, Inc. | 408.11 | -0.54 | -0.92 | -0.18 | Altimmune EPS beats by $0.22, beats on revenue [11/9/2020 4:45 PM] |
9.34 | 0.90 (19.14%) |
8.80 | 0.96 (12.32%) |
1.51 - 35.10 | 4,148,621 | 1,287,661 | 132,786 | |
|
|
||||||||||||||||||
| 11-08-2020 | AH | 7:15 AM ET (Aug 12) |
ALT | Altimmune, Inc. | 835.10 | -0.94 | -0.29 | -0.26 | Altimmune EPS misses by $0.66, misses on revenue [8/11/2020 4:26 PM] |
23.70 | 0.60 (2.58%) |
22.57 | -0.53 (-2.29%) |
1.51 - 35.10 | 1,488,112 | 1,950,339 | 19,149 | |
|
|
||||||||||||||||||
| 13-05-2020 | AH | 7:15 AM ET (May 14) |
ALT | Altimmune, Inc. | 56.84 | -0.26 | -0.32 | -0.27 | Altimmune EPS beats by $0.06, beats on revenue [5/13/2020 5:27 PM] |
4.49 | 0.36 (8.72%) |
4.62 | 0.13 (2.90%) |
1.51 - 5.74 | 20,194,490 | 1,249,407 | 78,162 | |
|
|
||||||||||||||||||